U.S. Markets closed

3 High-Yield Stocks at Rock-Bottom Prices

Keith Noonan, George Budwell, and Maxx Chatsko, The Motley Fool

Because yield is the proportion of a company's annual dividend payout relative to its stock price, it's not unusual to see stocks that offer big yields also trading at relatively low price-to-earnings multiples. However, a stock isn't necessarily cheap just because it has a big dividend and a P/E that is below the market average.

Instead of having unquestioned devotion to earnings multiples and yields, dividend investors will typically be best served by seeking out businesses that are also poised for the types of continued success that will allow payouts to keep flowing and growing. Within that mold, three Motley Fool contributors have identified Brookfield Renewable Partners LP (NYSE: BEP), AstraZeneca PLC (NYSE: AZN), and Hanesbrands (NYSE: HBI) as stocks with big yields that also trade at substantial discounts relative to their long-term earnings potential. Read on to find out why.

Hundred dollar bills in a glass jar.

Image source: Getty Images.

Diversifying its renewable portfolio

Maxx Chatsko (Brookfield Renewable Partners): Few companies bluntly state that their goal is to reward investors with long-term annualized total returns averaging 12% to 15%, but Brookfield Renewable Partners isn't shy about making that promise. A steady stream of growth investments on four continents has historically helped the business deliver, while an impressive distribution yield of 6.3% does a good bit of the heavy lifting, too.

However, the price of units has slipped 11% in the last year. Adding in hefty distribution payments only bumps up the total return to negative 5%, compared to a total return of 18% for the S&P 500 in that span. Investors shouldn't expect the trend to linger much longer.

The major contributing factor to the company's poor performance has been unusually weak North American hydroelectric dam output. Water runoff this year is 11% below the five-year average and 18% below an unusually strong 2018. That hurts Brookfield Renewable Partners because approximately 76% of its renewable electricity generation comes from hydropower. But some portfolio reshuffling this year should help the business get back on track and better diversify its future earnings mix.

Brookfield Renewable Partners is investing heavily in wind, solar, and storage projects, which are now among the cheapest sources of electricity generation. It also recently spent $420 million to increase its stake in TerraForm Power , which shares the same parent in Brookfield Infrastructure Partners , from 16% to 30%. TerraForm Power in turn used the capital to acquire 1,028 megawatts of European wind and solar capacity. While the recent diversification investments might take some time to show up in financial statements, the long-term potential -- and the ability to deliver on average annualized returns of 12% to 15% -- remain intact.

A big pharma on the comeback trail

George Budwell (AstraZeneca): Not long ago, Astra's above-average dividend yield of 3.74% appeared to be in real danger of being slashed or suspended outright. The company's pivot to immuno-oncology stalled after its checkpoint inhibitor Imfinzi failed to perform as hoped as a treatment for early stage lung cancer last year. However, Astra's fortunes have reversed course in a big way since this devastating clinical setback, putting its top-notch dividend on much firmer ground.

Turning to the specifics, last February Astra grabbed a highly lucrative label expansion for Imfinzi in stage 3 non-small-cell lung cancer in patients who have progressed after chemo and radiation therapy. And this week, the biopharma announced the approval of Lumoxiti in patients with the rare hairy-cell leukemia who have undergone at least two prior therapies. These two high-value approvals come on top of Calquence's approval in mantle cell lymphoma late last year, as well as improving sales of its other major oncology drugs Iressa, Lynparza, and Tagrisso in recent quarters.

Astra thus sports one of the more diverse and valuable oncology portfolios in the business. So, not surprisingly, Wall Street thinks the company can grow its top line by a whopping 7% per year for the next six years, according to a report by EvaluatePharma. And if this optimistic outlook holds, Astra's shares will turn out to be trading at only three times the company's 2024 sales. That forward-looking valuation is among the lowest within the large-cap biopharmaceutical space.

More important for income investors, though, this encouraging revenue forecast should comfortably support the company's top dividend program in the years to come. Bargain hunters and income investors alike, therefore, might want to buy into this compelling turnaround story soon.

Time-tested brands and a strong dividend

Keith Noonan  (Hanesbrands): Apparel company Hanesbrands' shares are down roughly 30% over the last year due to some weaker-than-expected earnings performance, and the fact that its contract with Target to exclusively carry the C9 Champion activewear line is not being renewed beyond January 2020.

Not everything is going well for the business, but Hanesbrands looks cheap, valued at just 10 times this year's expected earnings, and deserves the attention of value-focused dividend investors.

Shares yield roughly 3.4% at today's prices, comfortably above both the S&P 500 average yield of 1.8% and the 10-year Treasury bond (2.9%). Despite not delivering a payout increase within the last year, the company has tripled its payout over the last decade, and it still has substantial room for payout growth going forward. Hanesbrands generated enough free cash flow over the trailing 12-month period to cover its distribution twice over, and it expects to increase its cash flow roughly 80% over the next five-year period.

Despite losing roughly a year of sales with the C9 brand due to the lapsing Target deal, the company expects that the Champion brand will grow from $1.4 billion in 2017 to $2 billion in 2020. Beyond Champion and its namesake Hanes, the company also owns brands including Wonderbra and Playtex, which form a solid, dependable product portfolio. The business is expanding its international sales, adding new offerings through acquisitions, and trimming operating expenses. Patient investors could see a big payoff with Hanesbrands.

More From The Motley Fool

George Budwell owns shares of AstraZeneca. Keith Noonan has no position in any of the stocks mentioned. Maxx Chatsko has no position in any of the stocks mentioned. The Motley Fool recommends AstraZeneca and Brookfield Infrastructure Partners. The Motley Fool has a disclosure policy .

  • Can AMD Stock Go on a Bull Run Once Again?
    Business
    Motley Fool

    Can AMD Stock Go on a Bull Run Once Again?

    Advanced Micro Devices (NASDAQ: AMD) shares have fallen off a cliff over the past month, as investors are probably concerned about whether it can sustain its rally in the face of a fading tailwind and rising competition. The chipmaker has minted a lot of money thanks to cryptocurrency mining, but that catalyst is fizzling out and rival NVIDIA (NASDAQ: NVDA) has launched a new generation of graphics chips to reclaim its lost market share. AMD blames weak GPU sales to the cryptocurrency market for this slowdown, but recent developments indicate that it could easily surpass the low-balled guidance.

  • 3 Reasons Alibaba Stock Could Rise
    Business
    Motley Fool

    3 Reasons Alibaba Stock Could Rise

    After reaching an all-time high of $211.70 in June, Alibaba (NYSE: BABA) shares have shed nearly a third of their value as fears of an escalating trade war between China and the U.S. rattled investors. China's e-commerce market will grow to $1.8 trillion by 2022, according to Forrester, up from $1.1 trillion this year. With only 38% of China's 1.4 billion people currently making purchases online, this massive market is set to grow briskly for many years to come.

  • Which Canadian Marijuana Stock Will Enjoy a Bigger Bump From Its NYSE Listing -- Aphria or Aurora?
    Business
    Motley Fool

    Which Canadian Marijuana Stock Will Enjoy a Bigger Bump From Its NYSE Listing -- Aphria or Aurora?

    Maybe Wall Street should be called "Weed Street." Big Canadian marijuana grower Canopy Growth listed its stock on the New York Stock Exchange (NYSE) earlier this year. Aurora Cannabis (NASDAQOTH: ACBFF) begins trading on the NYSE on Tuesday, Oct. 23. Aphria (NASDAQOTH: APHQF) filed last week to list its stock on the NYSE.

  • 3 Dividend Stocks That Pay You More Than Coca-Cola Does
    Business
    Motley Fool

    3 Dividend Stocks That Pay You More Than Coca-Cola Does

    With a better than 50-year history of paying dividends, Coca-Cola (NYSE: KO) is seen as an icon of stable, strong, secure payouts. Although Coke and its dividend are not in trouble, there are better investments to be found. Three stocks that these Motley Fool contributors particularly like are Dominion Energy (NYSE: D), AbbVie (NYSE: ABBV), and MGM Growth Properties (NYSE: MGP).

  • This Warren Buffett Stock Is Dirt Cheap Right Now
    Business
    Motley Fool

    This Warren Buffett Stock Is Dirt Cheap Right Now

    Warren Buffett has amassed a large portfolio of bank stocks for Berkshire Hathaway (NYSE: BRK-A) (NYSE: BRK-B) with major holdings in Bank of America (NYSE: BAC), Wells Fargo (NYSE: WFC), and American Express (NYSE: AXP), just to name a few of the most well-known and largest investments. Synchrony is a major issuer of store-branded credit cards and also operates a rapidly growing online banking platform.

  • Better Buy: Ford Motor Company vs. General Motors
    Business
    Motley Fool

    Better Buy: Ford Motor Company vs. General Motors

    Both Ford Motor Company (NYSE: F) and General Motors (NYSE: GM) have been investor favorites in the not-too-distant past, and both pay good dividends. Ford has a slew of new products on the way, starting with a brand-new Ranger pickup early next year. Ford and GM have both had a rough year in the stock market.

  • Hate Taxes? 37 States Make Social Security Tax Free
    Business
    Motley Fool

    Hate Taxes? 37 States Make Social Security Tax Free

    Over the course of your career, you'll probably have tens of thousands of dollars in Social Security payroll taxes withheld from your paychecks. Workers are confident that by paying those taxes up front, they'll be able to collect Social Security benefits

  • Religious Extremists Got Their Justice. Now They're Going To Strip LGBTQ Rights.
    Politics
    HuffPost Opinion

    Religious Extremists Got Their Justice. Now They're Going To Strip LGBTQ Rights.

    While much of the country was in an uproar over the nomination (and confirmation) of Brett Kavanaugh to the U.S. Supreme Court, anti-LGBTQ religious extremists in Texas filed a federal lawsuit against the city of Austin targeting its anti-discrimination ordinance protecting LGBTQ people, claiming it infringes on their religious liberty. Like many municipalities and less than half of U.S. states, Austin protects gay, lesbian, bisexual and transgender people broadly from discrimination in housing, employment and public accommodations.

  • A Reduced Payout Could Be Coming for These 3 High-Yield Dividend Stocks
    Business
    Motley Fool

    A Reduced Payout Could Be Coming for These 3 High-Yield Dividend Stocks

    The bull market has been churning higher for nearly 10 years now as the S&P 500 has more than quadrupled since the market bottom in 2009. Investors in some high-yield dividend stocks may be worried about a payout cut, especially with rising interest rates making bonds more appealing. Let's take a closer look at three high-yield dividend stocks that could see a reduced payout.

  • Should Congress cut entitlement programs to combat rising deficit?
    Politics
    Fox Business Videos

    Should Congress cut entitlement programs to combat rising deficit?

    Maya MacGuineas, Committee for a Responsible Federal Budget, and Wall Street Journal editorial page deputy editor James Freeman discuss America’s deficit problem and how President Trump asked members of his Cabinet to cut their departments’ budgets by 5 percent.

  • 1 Top Stock to Buy Amid October’s Turbulent Market
    Business
    Motley Fool

    1 Top Stock to Buy Amid October’s Turbulent Market

    In the past three weeks alone, stocks have tumbled about 5%, which has many investors unnerved. One top option to consider amid the current turbulence is Magellan Midstream Partners (NYSE: MMP), which has lost more than 5% of its value in the past few weeks. Because of that, investors can get an even better starting price on one of the top master limited partnerships (MLPs), potentially setting themselves up to earn market-beating returns in the coming years.

  • Don’t cheat yourself with the 4% rule
    Business
    MarketWatch

    Don’t cheat yourself with the 4% rule

    If you’re planning for retirement, you’re probably thinking about how much you’ll need, how long the money will last, and how much you can safely take out each year. You recognize that in retirement there will be a balancing act between spending on current needs while also preserving enough for your later years. Instead, all-too-often, retirees use simplified rules of thumb to determine how much to take out each year.

  • 3 Warren Buffett Stocks Worth Buying Now
    Business
    Motley Fool

    3 Warren Buffett Stocks Worth Buying Now

    Known as the Oracle of Omaha, Warren Buffett has collected both an incredible investment record and a deservedly vast following among investors of all types. Every move he makes is scrutinized in the hope of gleaning  wisdom from his investment choices.

  • Rep. Gabbard on how US should respond to Khashoggi's death
    World
    Fox Business Videos

    Rep. Gabbard on how US should respond to Khashoggi's death

    Saudi prosecutors say 18 Saudis are being held as suspects in Jamal Khasoggi's death; reaction from Democratic Rep. Tulsi Gabbard.

  • Say Goodbye to Amazon's Blockbuster Revenue Growth
    Business
    Motley Fool

    Say Goodbye to Amazon's Blockbuster Revenue Growth

    Throughout its history, Amazon (NASDAQ: AMZN) has possessed a certain ingenuity in finding new ways to grow. Just when the company seems to be maturing in one sector, it finds a new one to jump into. Since the company's early history, its quarterly revenue growth has cycled between 15% and 50%, depending on where it is in the growth cycles in the above businesses.

  • Better Buy: Aurora Cannabis Inc. vs. Canopy Growth Corporation
    Business
    Motley Fool

    Better Buy: Aurora Cannabis Inc. vs. Canopy Growth Corporation

    Canadian marijuana producers have entered a new era. After several years of supplying medical marijuana nationwide, they have begun moving into Canada's recreational marijuana market, which opened on Oct. 17. Canopy's share price has soared three times higher than Aurora's has.

  • ExxonMobil vs. Chevron: Crude Prices Are Down, So Which Oil Stock Should You Buy?
    Finance
    GoBankingRates

    ExxonMobil vs. Chevron: Crude Prices Are Down, So Which Oil Stock Should You Buy?

    Slumping oil prices could hit oil companies hard.Chevron has more cash on hand to wait out reduced oil prices.ExxonMobil is the larger company and offers better value at its current price based on earnings and revenue.Oil prices have been on the decline

  • 3 Stocks to Supplement Your Social Security Income
    Business
    Motley Fool

    3 Stocks to Supplement Your Social Security Income

    Social Security isn't meant to replace your entire paycheck. Enterprise Products Partners L.P. (NYSE: EPD), Duke Energy Corporation (NYSE: DUK), and W.P. Carey Inc. (NYSE: WPC) are three great options to consider. Enterprise Products Partners is one of the largest midstream energy companies in North America, offering a generous distribution yield of roughly 6%.

  • How the Heck Did Netflix Stock Go Down Last Week?
    News
    Motley Fool

    How the Heck Did Netflix Stock Go Down Last Week?

    Everything seemed to go right for Netflix (NASDAQ: NFLX) last week. It has another hit on its hands with The Haunting of Hill House, an eight-part horror series based on Shirley Jackson's novel that has even won the praise of the immortal Stephen King. Netflix is killing it, but investors are unfortunately singing a different tune.

  • Sears Holdings Hopes to Live On After Bankruptcy. Here's Why It Won't
    Business
    Motley Fool

    Sears Holdings Hopes to Live On After Bankruptcy. Here's Why It Won't

    The bankruptcy filing everyone saw coming finally arrived. Sears Holdings (NASDAQ: SHLD) announced early Monday morning it was seeking Chapter 11 protection and had arranged financing that would allow it to keep operating, at least through Christmas. While other businesses have reorganized and emerged successfully while under the protection of the bankruptcy courts, including retailers like Payless ShoeSource, True Religion, and Gymboree, don't expect the same of Sears.

  • Suze Orman has a killer question for your retirement
    Business
    MarketWatch

    Suze Orman has a killer question for your retirement

    Suze Orman is one of those singular personalities in the financial business who seems to be right on the pulse of everyone she meets. She’s written books, starred in her own television show and made innumerable appearances in person. Like Oprah

  • Here's Which Marijuana Stocks Investors Are Betting Against the Most
    Business
    Motley Fool

    Here's Which Marijuana Stocks Investors Are Betting Against the Most

    Canada's recreational marijuana market is now open for business. Some are confident enough that certain marijuana stocks will fall that they're putting a lot of money on the line expecting that's exactly what will happen. The marijuana grower's low stock float and wild swings over the last month have received a lot of attention.

  • 3 Energy Stocks You Can Buy and Hold for the Next Decade
    Business
    Motley Fool

    3 Energy Stocks You Can Buy and Hold for the Next Decade

    North America needs to build $23 billion of new natural gas-related infrastructure annually through 2035, according to a recent report. Three of the best positioned to capture this growth are Kinder Morgan (NYSE: KMI), Williams Companies (NYSE: WMB), and TransCanada (NYSE: TRP), making them great stocks to buy and hold in the coming decade. Kinder Morgan is already the largest natural gas pipeline company in North America, operating roughly 70,000 miles of pipeline.

  • Get Ready for Intel Earnings
    Business
    Motley Fool

    Get Ready for Intel Earnings

    Ahead of Intel's earnings release, it's worth recapping what the company told investors to expect and what the analyst community is expecting. When Intel released its second-quarter financial results on July 26, it provided detailed financial guidance for the subsequent quarter, as well as for the full year. The company told investors to expect third-quarter revenue of between $17.6 billion and $18.6 billion and operating margin of "approximately" 32.5%.

  • The ‘smart money’ says it’s time to buy the Chinese internet giants and the U.S. FAANGs
    News
    MarketWatch

    The ‘smart money’ says it’s time to buy the Chinese internet giants and the U.S. FAANGs

    When the media and investors turn negative on stocks but the “smart money” is bullish, it’s a good time to think about buying. After all, exactly what is the smart money, and how do you know? Lately, several fund managers who pass this test have been pounding the table on Chinese internet names.